Michael Auerbach, Director at ATAI Life Sciences N.V. (ATAI), bought 4,666 shares at $15.00 ($70K) on 2021-06-22, disclosed to the SEC on 2021-06-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| TLRY | SELL | 2019-12-04 | $1.5M | — | Filing → |